title: Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.
abstract: Prostate cancer (CaP) is estimated to be first in incidence among cancers, with more than 240,000 new cases in 2012 in the United States. Chemokines and their receptors provide survival, proliferation, and invasion characteristics to CaP cells in both primary sites of cancer and metastatic locations. The emerging data demonstrate that many chemokines and their receptors are involved in the multistep process of CaP, leading to metastasis, and, further, that these factors act cooperatively to enhance other mechanisms of tumor cell survival, growth, and metastasis. Changes of chemokine receptor cohorts may be necessary to activate tumor-promoting signals. Chemokine receptors can activate downstream effectors, such as mitogen-activated protein kinases, by complex mechanisms of ligand-dependent activation of cryptic growth factors; guanosine triphosphate-binding, protein-coupled activation of survival kinases; or transactivation of other receptors such as ErbB family members. We describe vanguard research in which more than the classic view of chemokine receptor biology was clarified. Control of chemokines and inhibition of their receptor activation may add critical tools to reduce tumor growth, especially in chemo-hormonal refractory CaP that is both currently incurable and the most aggressive form of the disease, accounting for most of the more than 28,000 annual deaths.
authors.affiliation: Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami School of Medicine, Miami, Florida, USA.
authors.forename: Nicole
authors.initials: N
authors.lastname: Salazar
authors.forename: Miguel
authors.initials: M
authors.lastname: Castellan
authors.forename: Samir S
authors.initials: SS
authors.lastname: Shirodkar
authors.forename: Bal L
authors.initials: BL
authors.lastname: Lokeshwar
mesh_terms: D002470:Cell Survival; D002471:Cell Transformation, Neoplastic; D018925:Chemokines / Q000378:metabolism*; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D018925:Chemokines; D019707:Receptors, Chemokine
references.citation: Cancer Res. 2008 Dec 15;68(24):10367-76
references.pmid: 19074906
references.citation: Int J Cancer. 2009 Nov 15;125(10):2288-95
references.pmid: 19610059
references.citation: Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):628-32
references.pmid: 20018651
references.citation: Clin Cancer Res. 2000 May;6(5):2104-19
references.pmid: 10815938
references.citation: Mol Cancer Res. 2007 Jul;5(7):737-48
references.pmid: 17606477
references.citation: J Cancer Sci Ther. 2010;2(4):89-94
references.pmid: 20808724
references.citation: Cancer Res. 2011 May 1;71(9):3268-77
references.pmid: 21398406
references.citation: J Biol Chem. 1998 Feb 13;273(7):4282-7
references.pmid: 9461627
references.citation: Cancer Sci. 2008 Jul;99(7):1362-9
references.pmid: 18452560
references.citation: Clin Cancer Res. 2008 Jul 1;14(13):4111-8
references.pmid: 18593988
references.citation: Ann Pharmacother. 2012 Nov;46(11):1518-28
references.pmid: 23136351
references.citation: Exp Cell Res. 2012 Nov 15;318(19):2507-19
references.pmid: 22841689
references.citation: Biochem Biophys Res Commun. 1987 Dec 16;149(2):755-61
references.pmid: 3322281
references.citation: Mol Cancer Res. 2008 Mar;6(3):446-57
references.pmid: 18337451
references.citation: Cancer Lett. 2009 Sep 28;283(1):29-35
references.pmid: 19375853
references.citation: Cancer Res. 1999 Nov 15;59(22):5830-5
references.pmid: 10582706
references.citation: Cancer Res. 2007 Jul 15;67(14):6854-62
references.pmid: 17638896
references.citation: Cell Signal. 2005 Dec;17(12):1578-92
references.pmid: 16005185
references.citation: Biochem Biophys Res Commun. 2004 Jul 30;320(3):656-63
references.pmid: 15240098
references.citation: Clin Cancer Res. 2005 Jun 1;11(11):4117-27
references.pmid: 15930347
references.citation: J Biol Chem. 1995 Nov 10;270(45):27348-57
references.pmid: 7592998
references.citation: Cell. 2010 Apr 2;141(1):52-67
references.pmid: 20371345
references.citation: Cell Prolif. 2011 Aug;44(4):311-9
references.pmid: 21645150
references.citation: Mol Cancer. 2012 Jan 11;11:3
references.pmid: 22236567
references.citation: J Urol. 1998 Oct;160(4):1220-9
references.pmid: 9751323
references.citation: J Immunol. 2009 Sep 1;183(5):2898-901
references.pmid: 19696429
references.citation: Nature. 2011 Feb 24;470(7335):548-53
references.pmid: 21326202
references.citation: Urol Oncol. 2005 Jul-Aug;23(4):261-7
references.pmid: 16018941
references.citation: Prostate. 2006 Sep 1;66(12):1311-8
references.pmid: 16705739
references.citation: J Exp Ther Oncol. 2004 Dec;4(4):291-303
references.pmid: 15844659
references.citation: Urol Oncol. 2007 Sep-Oct;25(5):413-9
references.pmid: 17826663
references.citation: Genome Biol. 2006;7(12):243
references.pmid: 17201934
references.citation: J Pharmacol Exp Ther. 2008 Dec;327(3):746-59
references.pmid: 18780829
references.citation: J Biol Chem. 2007 Sep 14;282(37):26767-26774
references.pmid: 17631494
references.citation: J Biol Chem. 2009 Jul 31;284(31):20927-35
references.pmid: 19525223
references.citation: Am J Pathol. 1999 May;154(5):1503-12
references.pmid: 10329603
references.citation: Proc Natl Acad Sci U S A. 1987 Dec;84(24):9233-7
references.pmid: 3480540
references.citation: Cancer Sci. 2008 Mar;99(3):539-42
references.pmid: 18201276
references.citation: Cancer Res. 2002 Mar 15;62(6):1832-7
references.pmid: 11912162
references.citation: Prostate. 2006 Dec 1;66(16):1721-8
references.pmid: 16941672
references.citation: Prostate. 2005 Jun 15;64(1):40-9
references.pmid: 15651067
references.citation: Science. 1991 Sep 13;253(5025):1278-80
references.pmid: 1840701
references.citation: Mutat Res. 2003 Dec 10;533(1-2):107-20
references.pmid: 14643415
references.citation: Nature. 2008 Jul 24;454(7203):436-44
references.pmid: 18650914
references.citation: Neoplasia. 2006 Apr;8(4):290-301
references.pmid: 16756721
references.citation: J Cell Biochem. 2007 Jun 1;101(3):676-85
references.pmid: 17216598
references.citation: Annu Rev Immunol. 2007;25:787-820
references.pmid: 17291188
references.citation: Mol Cell Endocrinol. 2012 Apr 4;351(2):249-63
references.pmid: 22245379
references.citation: J Cell Biochem. 2003 Jun 1;89(3):462-73
references.pmid: 12761880
references.citation: Clin Cancer Res. 2004 Dec 15;10(24):8743-50
references.pmid: 15623660
references.citation: Urol Clin North Am. 2012 Nov;39(4):465-81
references.pmid: 23084524
references.citation: J Leukoc Biol. 2009 Sep;86(3):529-43
references.pmid: 19564575
references.citation: J Biol Chem. 1996 Aug 23;271(34):20545-50
references.pmid: 8702798
references.citation: Technol Cancer Res Treat. 2004 Oct;3(5):411
references.pmid: 15453805
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):6735-41
references.pmid: 18980965
references.citation: Life Sci. 2006 Mar 13;78(16):1784-93
references.pmid: 16263140
references.citation: Oncol Rep. 2006 Oct;16(4):831-6
references.pmid: 16969502
references.citation: FASEB J. 2004 Aug;18(11):1240-2
references.pmid: 15180966
references.citation: Cancer Res. 2009 Nov 1;69(21):8265-74
references.pmid: 19861539
references.citation: Cancer Res. 2005 Apr 15;65(8):3470-8
references.pmid: 15833883
references.citation: J Biol Chem. 2012 Apr 13;287(16):12952-65
references.pmid: 22371491
references.citation: J Bone Miner Res. 2005 Feb;20(2):318-29
references.pmid: 15647826
references.citation: Am J Pathol. 2005 Jun;166(6):1807-15
references.pmid: 15920165
references.citation: Nat Cell Biol. 2006 Dec;8(12):1369-75
references.pmid: 17128264
references.citation: J Clin Invest. 2001 Mar;107(5):595-601
references.pmid: 11238560
references.citation: Nature. 2001 Mar 1;410(6824):50-6
references.pmid: 11242036
references.citation: J Biol Chem. 2008 Feb 15;283(7):4283-94
references.pmid: 18057003
references.citation: Prostate. 2006 Feb 1;66(2):124-34
references.pmid: 16161154